Document Detail

Early changes in the permeability of the blood-brain barrier produced by toxins associated with liver failure.
MedLine Citation:
PMID:  2235119     Owner:  NLM     Status:  MEDLINE    
Our study was designed to determine whether substances that appear in the serum during the course of liver failure have a detrimental effect on the passive permeability of the blood-brain [blood-cerebrospinal fluid (CSF)] barrier. Lactic acid, octanoic acid, and ammonia were infused into rabbits for 4 h. The permeability changes of the blood-brain barrier were quantified by infusing polyethylene glycol 400 (PEG 400) and measuring the quantity and average mol wt of the PEG 400 that entered the CSF. The lipid solubility and effective diffusional radius of the PEG molecules were also quantified to provide greater precision for measurements using this probe. None of the animals receiving toxic infusions became seriously ill during the infusions. Low dose infusions of lactic acid, octanoic acid, and ammonia increased the effective pore diameter of the blood-brain barrier from 7.3 A to an average of 8.5 A. The amount of PEG entering the CSF increased from 1.7 to 4.0 (p less than 0.025), 4.7 (p less than 0.025), and 6.7 (p less than 0.001) mmol/L, respectively. Rabbits with galactosamine-induced liver failure had 10.1 mmol/L PEG 400 in the CSF (P less than 0.001) before any evidence of cerebral edema. These changes occur soon after these toxins accumulate in the plasma and may alone or together with other toxins account for the permeability changes that allow neurotoxic substances to enter the brain during hepatic disease and encephalopathies such as Reye's syndrome.
H J McClung; H R Sloan; P Powers; A J Merola; R Murray; B Kerzner; J D Pollack
Related Documents :
2155669 - 31p-nmr studies on time-course of change in the blood-brain barrier after treatment wit...
23092679 - New insights in the pathogenesis and treatment of normal tension glaucoma.
1905059 - Effects of intravenous and aerosolized arachidonic acid on alveolar epithelial permeabi...
12865899 - How does the benzamide antipsychotic amisulpride get into the brain?--an in vitro appro...
22471429 - Interaction of fibrin with red blood cells: the role of iron.
11778669 - Neurotoxicology of the brain barrier system: new implications.
19590749 - Polyionic polymers--heterogeneous media for metal nanoparticles as catalyst in suzuki-m...
4850939 - Cerebral blood flow, internal carotid artery pressure, and the eeg as a guide to the sa...
1434599 - Limiting oxygen delivery attenuates intestinal reperfusion injury.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pediatric research     Volume:  28     ISSN:  0031-3998     ISO Abbreviation:  Pediatr. Res.     Publication Date:  1990 Sep 
Date Detail:
Created Date:  1990-12-07     Completed Date:  1990-12-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0100714     Medline TA:  Pediatr Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  227-31     Citation Subset:  IM    
Department of Pediatrics, Children's Hospital, Columbus, Ohio 43205.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood-Brain Barrier / drug effects*,  physiology
Endothelium, Vascular / drug effects,  metabolism
Hepatic Encephalopathy / blood,  etiology,  physiopathology*
Polyethylene Glycols
Toxins, Biological / blood,  toxicity*
Reg. No./Substance:
0/Polyethylene Glycols; 0/Toxins, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Reversal of venous blood flow with atrial tachycardia and hydrops in fetal sheep.
Next Document:  Effect of gentamicin on the auditory brainstem evoked response in term infants: a preliminary report...